Plant-Based GLP-1 Modulation for Glucose, Appetite, and Weight Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current GLP-1RA drugs for treating type 2 diabetes and obesity have limitations such as gastrointestinal distress, hypoglycemia, pancreatitis, renal impairment, and immunogenicity, necessitating the need for safer and healthier alternatives for blood glucose control, appetite control, and weight management.
Innovation Solution
A plant-based composition comprising green tea leaf extract, gardenia fructus fruit powder, turmeric root extract, black pepper extract, fenugreek seed extract, and ginseng root extract, which modulates the endogenous secretion and activity of glucagon-like peptide 1 (GLP-1) to enhance hormone signaling, blood glucose control, and weight management.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If GLP-1RA drugs are used for blood glucose control and weight management, then efficacy is improved, but harmful side effects occur
Solution Approach 1:
The patent replaces synthetic GLP-1RA drugs with natural plant-based compounds (green tea extract, gardenia fructus, turmeric root, black pepper, fenugreek seed, ginseng root, white kidney bean) that provide similar GLP-1 modulation effects without the harmful side effects. These natural alternatives act as temporary, safe substitutes that achieve the desired therapeutic effect without long-term accumulation of harm.
Solution Approach 2:
The patent introduces natural plant extracts as intermediary substances that mediate between the desired therapeutic effect (GLP-1 secretion stimulation) and the harmful effects of synthetic drugs. These intermediaries (natural compounds) achieve the same physiological outcome through different mechanisms that do not cause the adverse effects associated with conventional GLP-1RA medications.
2Reliability
If synthetic GLP-1RA medications are administered, then blood glucose control is achieved, but gastrointestinal distress and other adverse effects occur
Solution Approach 1:
The patent substitutes the synthetic pharmaceutical mechanism with a natural botanical mechanism. Instead of using chemically synthesized GLP-1 analogs that directly stimulate receptors and cause gastrointestinal distress, the invention uses natural plant compounds that gently modulate endogenous GLP-1 secretion through complex biochemical pathways, achieving the same blood glucose control without mechanical harshness.
Solution Approach 2:
The patent changes the chemical and physiological parameters of the treatment approach. Rather than using high-potency synthetic peptides that cause adverse effects at therapeutic doses, the invention uses natural compounds with different chemical properties that achieve GLP-1 modulation through gradual, physiologically compatible parameter changes, thereby avoiding gastrointestinal distress and other harmful effects.
Data Source
AI summary
A composition for hormone signaling, blood glucose control, appetite control, and weight management is provided. The composition includes green tea leaf extract, gardenia fructus fruit powder, turmeric root extract, black pepper extract, fenugreek seed extract, ginseng root extract, and white kidney bean extract. A method for hormone signaling, blood glucose control, appetite control, and weight management is provided, comprising administering to the mammal the composition.